HealthUS FDA to hold advisory meeting on Grail’s multi-cancer test
Grail said on Friday that the U.S. Food and Drug Administration plans to convene outside experts in September. The advisory meeting will examine Galleri, Grail’s multi-cancer screening test. Grail shares rose 5% after the announcement. The review could bring additional regulatory attention to the test.
R
Reuters★★☆☆☆2026-08-07 19:01Original
US FDA to hold advisory meeting on Grail’s multi-cancer test
Health